SYMBOL
 
SurgiLight Logo SurgiLight, Inc. (OTCBB: SRGL)

SurgiLight, Inc. News and Articles

Report by TheStockBroker.com

Article in Ophthamology Times

Article in Ophthamology Times - LAPR

PRESBYOPIC TREATMENT BY LASER ASSISTED SCLERECTOMY

One Year Clinical Results of LAPR

CLINICAL OUTCOMES AND THEORY OF OPTIVISION™ LASER PRESBYOPIA REVERSAL

Positive Results Seen at 12 Months


Recent News Releases from SurgiLight, Inc.:

SurgiLight News - 4-6-05

SurgiLight News - 10-03

SurgiLight News - 11-30-04

SurgiLight News - 02-02-05

SurgiLight News - 02-23-05



Disclaimer:
All material herein is information supplied by the company or other sources believed to be reliable. The information contained herein is not guaranteed by TheNewsGate.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this profile have approved the statements made in this profile. This profile contains forward-looking statements that involve risks and uncertainties. Statements in this press release about the company's future expectations, including: development of licensing and branding and all other statements in this release, other than historical facts, are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, section 21E of the Securities Act of 1934, as that term is defined in the Private Securities Reform Act of 1995. It is important to note that actual results and ultimate corporate actions could differ materially from those in such forward looking statements. Such "forward-looking statements" are subject to risks and uncertainties set forth from time to time in the Company's SEC reports. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. TheNewsGate.com is not a licensed broker, broker dealer, market marker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://TheNewsGate.com/ TheNewsGate.com's affiliates, officers, directors and employees may have bought or may buy the shares discussed in this profile and may profit in the event those shares rise in value. TheNewsGate.com does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

 
   
     
 
TheNewsGate.com Home Stock Profiles Penny Stock Education Advertise with TheNewsGate.com Financial Links